TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34857420

Group type: EXPERIMENTAL
Intervention: One dose of bivalent HPV vaccine
Number of subjects: 20330

Group type: EXPERIMENTAL
Intervention: Two doses of bivalent HPV vaccine
Number of subjects: 20330

Group type: EXPERIMENTAL
Intervention: One dose of nonavalent HPV vaccine
Number of subjects: 20330

Group type: EXPERIMENTAL
Intervention: Two doses of nonavalent HPV vaccine
Number of subjects: 20330

Group type: COMPARATOR
Intervention: Unvaccinated women
Number of subjects: 20330
Study: 33825687

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT), 8-week intervention, therapist-guided
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 63
Study: 36201851

Group type: EXPERIMENTAL
Intervention: 8-week group weight management program, ShipShape
Number of subjects: 178

Group type: COMPARATOR
Intervention: ShipShape enhanced with acceptance and commitment therapy
Number of subjects: 178
Study: 32633067

Group type: EXPERIMENTAL
Intervention: FVIII concentration measured with liquid chromatography‐tandem mass spectrometry (LC‐MS/MS)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Presence of anti‐FVIII antibodies
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Use of exogenous FVIII products
Number of subjects: 87
Study: 34380854

Group type: EXPERIMENTAL
Intervention: Educational-supportive program in 3 weekly sessions
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 140
Study: 32029537

Group type: EXPERIMENTAL
Intervention: Reduced risk claim
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Reduced exposure claim
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (neither claim)
Number of subjects: 450
Study: 35255096

Group type: COMPARATOR
Intervention: Thermotherapy (TT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Thermotherapy (TT) plus a short course of miltefosine (MLT)
Number of subjects: 130
Study: 34006388

Group type: EXPERIMENTAL
Intervention: Nigella sativa (NS) oil soft gelatin capsules 450 mg twice daily
Number of subjects: 117

Group type: COMPARATOR
Intervention: Lifestyle modification (LM)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Metformin (Met) 500 mg tablets twice daily
Number of subjects: 117
Study: 32917187

Group type: EXPERIMENTAL
Intervention: Training program on Nursing Informatics (NI) competency delivered in a three-day workshop.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 60
Study: 35093682

Group type: EXPERIMENTAL
Intervention: Oncotype DX test
Number of subjects: 10000

Group type: COMPARATOR
Intervention: EndoPredict test
Number of subjects: 10000

Group type: COMPARATOR
Intervention: MammaPrint test
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Prosigna test
Number of subjects: 10000
Study: 33573741

Group type: EXPERIMENTAL
Intervention: Surgery for ischemic mitral valve regurgitation (IMR)
Number of subjects: 492
Study: 32349193

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 233

Group type: COMPARATOR
Intervention: Glimepiride 0.5 mg
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg (subgroup with preserved LVEF)
Number of subjects: 233
Study: 35568490

Group type: EXPERIMENTAL
Intervention: Handwashing with water and wood ash
Number of subjects: 440

Group type: COMPARATOR
Intervention: Handwashing with water alone
Number of subjects: 440
Study: 36227509

Group type: EXPERIMENTAL
Intervention: Intermittently scanned continuous glucose monitoring (isCGM) system
Number of subjects: 122
Study: 32043342

Group type: COMPARATOR
Intervention: HIIT
Number of subjects: 30

Group type: COMPARATOR
Intervention: CA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CA+NMES
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HIIT+NMES
Number of subjects: 30
Study: 33740348

Group type: EXPERIMENTAL
Intervention: Ropivacaine group (0.375% ropivacaine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline group (mock ESPB with saline)
Number of subjects: 0
Study: 32497783

Group type: EXPERIMENTAL
Intervention: Peer support arm
Number of subjects: 296

Group type: COMPARATOR
Intervention: Enhanced usual care arm
Number of subjects: 296
Study: 35281316

Group type: EXPERIMENTAL
Intervention: YYD601 30 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: YYD601 40 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: YYD601 60 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 32
Study: 33462323

Group type: EXPERIMENTAL
Intervention: Late implant placement following alveolar ridge preservation (LP/ARP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Early implantation (EP)
Number of subjects: 16
Study: 32998920

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intravenous dexamethasone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34263442

Group type: EXPERIMENTAL
Intervention: Danhong Injection (DH)
Number of subjects: 78
Study: 32345649

Group type: EXPERIMENTAL
Intervention: cRGD-ZW800-1 at 0.05 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cRGD-ZW800-1 at 0.005 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cRGD-ZW800-1 at 0.015 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cRGD-ZW800-1
Number of subjects: 12
Study: 32244890

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) assessed using the Godin-Shephard Leisure-Time Exercise Questionnaire (GSLTPAQ)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Leisure-time activity assessed using the Physical Activity Questionnaire for Older Children (PAQ-C)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Screen time
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels
Number of subjects: 275
Study: 36122378

Group type: EXPERIMENTAL
Intervention: Unsupervised online yoga program (12 weeks, 1 video per week, performed 3 times per week)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Unsupervised online yoga program
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control (online osteoarthritis information)
Number of subjects: 212
Study: 36464887

Group type: EXPERIMENTAL
Intervention: Single ambulatory phlebectomy (SAP)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Saphenous thermal ablation with concomitant phlebectomy (TAP)
Number of subjects: 464
Study: 34297719

Group type: EXPERIMENTAL
Intervention: Mailed information about the centre and a free entry pass
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Minimal intervention supplemented by customer relations management support
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Control condition (public awareness raising)
Number of subjects: 1320
Study: 34435795

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Standard patient interactions
Number of subjects: 641
Study: 33160420

Group type: EXPERIMENTAL
Intervention: tDCS-assisted cognitive training with anodal tDCS over left DLPFC
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cognitive training plus sham stimulation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: tDCS-assisted cognitive training
Number of subjects: 46
Study: 36181015

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg then 4 mg/kg/h)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 68
Study: 33430839

Group type: EXPERIMENTAL
Intervention: IlluminOss® Photodynamic Bone Stabilization System
Number of subjects: 12
Study: 35115099

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4330
Study: 33825411

Group type: EXPERIMENTAL
Intervention: Hemoheal cream
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33385203

Group type: EXPERIMENTAL
Intervention: Lower-target glucose control
Number of subjects: 1476

Group type: COMPARATOR
Intervention: Higher-target glucose control
Number of subjects: 1476
Study: 33110042

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (400 IU of 25-hydroxyvitamin-D and 1,000 mg of calcium per day)
Number of subjects: 20050

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20050
Study: 32016523

Group type: EXPERIMENTAL
Intervention: Acoustic parameters (snoring index, percentage snoring time, sound pressure level, sound energy, loudness, psychoacoustic annoyance, psychoacoustic snore score) measured during treatment.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mean sound energy LAeq over the entire night after intervention.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control night measurements (not specified).
Number of subjects: 18
Study: 33211672

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 6201

Group type: COMPARATOR
Intervention: No BCG vaccination (Control)
Number of subjects: 6201
Study: 32216138

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: DBT + DBT Prolonged Exposure (DBT PE)
Number of subjects: 26
Study: 36062574

Group type: EXPERIMENTAL
Intervention: Immediate Treatment Group (ITG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Later Treatment Group (LTG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups (ITG and LTG)
Number of subjects: 75
Study: 34462278

Group type: EXPERIMENTAL
Intervention: New Nordic Renal Diet (NNRD) with a dietary phosphorus intake reduction to 850 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-restricted habitual diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: New Nordic Renal Diet (NNRD)
Number of subjects: 60
Study: 32220893

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) plus 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) and 5-fluorouracil/leucovorin/irinotecan (FOLFIRI)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Higher levels of post-induction mAF and post-induction mean mutant molecules per milliliter (mMMPM)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Changes in ctDNA (stratified by a 10-fold or 100-fold reduction in mAF between pre- and post-induction plasma)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Post-induction mAF and mMMPM
Number of subjects: 280
Study: 35600332

Group type: EXPERIMENTAL
Intervention: TCM decoction combined with acupuncture and moxibustion (A&M) treatment based on syndrome differentiation and treatment (SDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation (CCR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TCM decoction combined with A&M
Number of subjects: 0
Study: 34687869

Group type: EXPERIMENTAL
Intervention: Benson relaxation (BR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 120
Study: 34455804

Group type: EXPERIMENTAL
Intervention: Isolate treatments (Sclerotinia sclerotiorum) on fruit inoculation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Isolate treatments (Sclerotinia sclerotiorum) on petiole inoculation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Mock-inoculated controls (PDA plug only) on fruit
Number of subjects: 3

Group type: COMPARATOR
Intervention: Mock-inoculated controls (sterile PDA) on petioles
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Comparison of stem rot susceptibility among four cultivars
Number of subjects: 3
Study: 34599925

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (healthy school lunch-box)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (150 min of planned in-school physical activity)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Combined physical activity and nutrition
Number of subjects: 742

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 742
Study: 32954762

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment of suprascapular and axillary nerves
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nerve block treatment of suprascapular and axillary nerves
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nerve block treatment
Number of subjects: 20
Study: 35648636

Group type: EXPERIMENTAL
Intervention: Emotion-Focused Skills Training (EFST) - experiential condition (n = 120)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Psychoeducational only condition (n = 116)
Number of subjects: 236
Study: 33186735

Group type: EXPERIMENTAL
Intervention: Cerebral autoregulation monitoring for MAP targets during CPB
Number of subjects: 460

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 460
Study: 35587063

Group type: EXPERIMENTAL
Intervention: Nitazoxanide-based triple therapy (nitazoxanide, proton pump inhibitor, and clarithromycin) for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metronidazole-based standard treatment (metronidazole, omeprazole, and clarithromycin) for 14 days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nitazoxanide-based triple therapy
Number of subjects: 100
Study: 34792396

Group type: EXPERIMENTAL
Intervention: 5 × 45-min educational sessions based on the Multi-Theory Model
Number of subjects: 80

Group type: COMPARATOR
Intervention: Health advice (Control)
Number of subjects: 80
Study: 33579203

Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS) calculated from 22 CRC risk-associated SNPs
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: GRS categories: low (< 0.5), average (0.5–1.5), elevated (> 1.5)
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Higher GRS
Number of subjects: 1769

Group type: COMPARATOR
Intervention: Positive family history
Number of subjects: 1769
Study: 32030454

Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation (100% lavender oil for 3 minutes)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no prior application)
Number of subjects: 126
Study: 36203135

Group type: EXPERIMENTAL
Intervention: Combined use of smartphone application and fitness bracelet for 3 months alongside brief lifestyle counselling.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Brief lifestyle counselling alone (Control Group).
Number of subjects: 160
Study: 32301671

Group type: EXPERIMENTAL
Intervention: NIR laser at 2.4 J/cm2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: red+NIR laser at 2.4 J/cm2
Number of subjects: 30

Group type: COMPARATOR
Intervention: red laser at 0.6 J/cm2
Number of subjects: 30

Group type: COMPARATOR
Intervention: red+NIR lasers at 0.6 J/cm2
Number of subjects: 30

Group type: COMPARATOR
Intervention: red+NIR lasers at 1.2 J/cm2
Number of subjects: 30

Group type: COMPARATOR
Intervention: red+NIR lasers at 2.4 J/cm2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: red laser at 2.4 J/cm2
Number of subjects: 30
Study: 35462552

Group type: EXPERIMENTAL
Intervention: Paclitaxel + carboplatin (group A1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Eribulin + carboplatin (A2)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Eribulin + cyclophosphamide (B1)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Eribulin + capecitabine (B2)
Number of subjects: 66
Study: 32896692

Group type: EXPERIMENTAL
Intervention: MSK-HQ
Number of subjects: 524

Group type: COMPARATOR
Intervention: EQ-5D-5L
Number of subjects: 524

Group type: COMPARATOR
Intervention: site-specific PROMs
Number of subjects: 524

Group type: COMPARATOR
Intervention: SF-12
Number of subjects: 524
Study: 35226221

Group type: EXPERIMENTAL
Intervention: CCTA-guided ICA (n = 115)
Number of subjects: 220

Group type: COMPARATOR
Intervention: NIST-guided ICA (n = 105)
Number of subjects: 220
Study: 33284944

Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 28
Study: 34048073

Group type: EXPERIMENTAL
Intervention: Periodontal health education session (PHES)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard oral hygiene education (control group)
Number of subjects: 50
Study: 33160161

Group type: EXPERIMENTAL
Intervention: LPG intervention group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (biomass)
Number of subjects: 100
Study: 32678998

Group type: EXPERIMENTAL
Intervention: Manualised psychological treatment for tinnitus, details on dosage and duration not specified.
Number of subjects: 9

Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 9
Study: 34982954

Group type: COMPARATOR
Intervention: Reading comprehension measures (DS group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Listening comprehension measures (DS group)
Number of subjects: 38
Study: 34143220

Group type: EXPERIMENTAL
Intervention: HPactive
Number of subjects: 22

Group type: COMPARATOR
Intervention: HPpassive
Number of subjects: 22
Study: 35468589

Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing (6 breaths/min)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Paced breathing (12 breaths/min)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no instructions)
Number of subjects: 67
Study: 34294137

Group type: EXPERIMENTAL
Intervention: self‐paced walking with real‐time feedback
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: self‐paced walking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: self‐paced walking with an internal focus of attention
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: speed-matched walking
Number of subjects: 30
Study: 35687187

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 180

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 180
Study: 34769797

Group type: EXPERIMENTAL
Intervention: Continuous Aerobic Training (CAT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intermittent Aerobic Training (IAT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Non-training Control Group (CG)
Number of subjects: 87
Study: 32300362

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (20% > lactate threshold)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (35% < lactate threshold)
Number of subjects: 22
Study: 35850126

Group type: EXPERIMENTAL
Intervention: Single dose of casirivimab and imdevimab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32203207

Group type: EXPERIMENTAL
Intervention: Trastuzumab (T) + Lapatinib (L)
Number of subjects: 4190

Group type: COMPARATOR
Intervention: Trastuzumab (T)
Number of subjects: 4190

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 4190
Study: 35672756

Group type: EXPERIMENTAL
Intervention: Transcutaneous peroneal nerve stimulator (tPNS) during gait training for 3 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional home and/or community gait training therapy (CT) for 3 weeks
Number of subjects: 31
Study: 32289283

Group type: EXPERIMENTAL
Intervention: 20 sessions of systemic cryostimulation at -120°C for 2-3 min
Number of subjects: 21
Study: 35970655

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Bilevel Positive Airway Pressure (BPAP)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study: 33452180

Group type: EXPERIMENTAL
Intervention: Etanercept monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MTX + Etanercept combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 0
Study: 32715946

Group type: EXPERIMENTAL
Intervention: New prediction models developed from VO2peak using 20 m-SR
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Model with BMI-z for girls
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Model with BMI-z and %FM for boys
Number of subjects: 148
Study: 35860183

Group type: EXPERIMENTAL
Intervention: Algoplaque hydrocolloid dressing (AHD) combined with nanosilver antibacterial gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gauzes (Control)
Number of subjects: 100
Study: 32983558

Group type: EXPERIMENTAL
Intervention: Theoretically informed physical activity intervention
Number of subjects: 20
Study: 32286686

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (25 mg orally twice daily from days 8-12) + Clomiphene citrate (100 mg once daily from days 3-7)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg once daily from days 3-7)
Number of subjects: 80
Study: 35725945

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 192
Study: 33485455

Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg infusions at 2-week intervals)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg infusions at 4-week intervals)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 164

Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 164
Study: 33738615

Group type: EXPERIMENTAL
Intervention: Laser acupuncture tele-therapy in addition to methotrexate and aerobic exercise training (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methotrexate and aerobic exercise training (group B)
Number of subjects: 60
Study: 32757272

Group type: EXPERIMENTAL
Intervention: Local Muscle Vibration (LMV)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 36272125

Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS) post-crossover
Number of subjects: 159
Study: 34510104

Group type: EXPERIMENTAL
Intervention: Group medical visits with medication management plus low carbohydrate diet-focused weight management (WM/GMV; n=127)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Group medical visits with medication management alone (GMV; n=136)
Number of subjects: 263
Study: 36102618

Group type: EXPERIMENTAL
Intervention: Lung Volume Recruitment (LVR), used twice-daily as part of a randomized controlled trial
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lung Volume Recruitment (LVR)
Number of subjects: 11
Study: 32504880

Group type: EXPERIMENTAL
Intervention: SSRI-exposed children
Number of subjects: 111

Group type: COMPARATOR
Intervention: Non-SSRI-exposed children
Number of subjects: 111